In October 2022 the FDA announced a potential shortage of ADHD medications in the United States. The impact continues to be felt a year later, with many alternative stimulants also experiencing intermittent shortages or limited availability. The VHAN Pharmacy Team put together helpful strategies you can incorporate to navigate the stimulant shortage successfully.
Several of VHAN’s contracts include triple-weighted measures, which have a larger impact on quality results. Medication adherence is particularly important, as it is triple weighted across all Medicare Advantage (MA) contracts. Additionally, medication adherence provides an opportunity for year-round focus and impact, unlike other measures that may be addressed at certain times throughout the year. VHAN’s Pharmacy Team offers tools to help your patients with medication adherence.
Signed into law in August 2022, the Inflation Reduction Act (IRA) includes provisions to lower health care and medication costs over the next several years. This article outlines a few key implications of which providers should be aware.
In recent years the VHAN Population Health Pharmacy Team has made it a priority to help patients, particularly ones with chronic illnesses, improve compliance to their prescriptions. This focus on medication adherence not only helps patients better manage their chronic diseases, but it also helps maintain consistent medical care during transitions and even reduce drug costs. It’s all part of the team’s efforts to produce better patient outcomes.
In recent months, demand for GLP1 (glucagon like peptide 1) receptor agonists has skyrocketed across the country, leaving providers inundated with prescription requests and patients frustrated with shortages. GLP1 agonists have an important place in obesity therapy. However, there are many unanswered questions about long-term side effects, cost-effectiveness and the duration of therapy. Unfortunately, current manufacturing cannot adequately meet the demand for both diabetes and obesity treatment. The VHAN Pharmacy Team has the following recommendations for navigating ongoing shortages.
Coordinated care provides multiple touchpoints to ensure that no symptom goes untreated, and no patient falls through the cracks. At Vanderbilt Health Affiliated Network (VHAN), clinical pharmacists, social workers and nurse care navigators collaborate to deliver proactive, timely care to patients who need it most.
For Population Health Clinical Pharmacist Lauren Cook, PharmD, BCPS, BCACP, VHAN’s cooperative approach means staying alert for complications that may arise unexpectedly with patients. Cook’s vigilance recently helped a 64-year-old blind patient avoid a potentially catastrophic health event.
On December 6, VHAN experts Jacky Bradley, PharmD, MBA, and Sophie Katz, MD, facilitated a Learning Exchange for network members to share best practices and learn how to leverage the resources from VHAN’s new Antibiotic Stewardship Program.
Antibiotics prevent millions of deaths each year, fighting bacterial infections that could otherwise lead to serious complications or even death. But after years of overuse and inappropriate prescription, various bacteria have become increasingly resistant to antibiotics. To ensure optimum use of antibiotics and other antimicrobial drugs at Vanderbilt University Medical Center (VUMC), a team of physicians and pharmacists created the Vanderbilt Antimicrobial Stewardship Program (VASP). Learn more about the program’s successes in this case study.
At least 30% of outpatient-prescribed antibiotics are unnecessary, sometimes leading to ER visits for adverse drug events in patients of all ages. To increase the appropriate use of antibiotics and decrease the threat of antibiotic resistance, VHAN has launched a new Antibiotic Stewardship Program, focusing on Upper Respiratory Infections (URIs) in the first phase.